- Home
- Companies
- usa florida
- epilepsy
Refine by
Epilepsy Suppliers Serving Usa Florida
5 companies found
Technologybased inSouth San Francisco, CALIFORNIA (USA)
Neurona Therapeutics is driven by rigorous scientific discovery and focused on developing breakthrough treatments for neurological disorders. Neurona Therapeutics is a privately-held, clinical-stage biotherapeutics company focused on discovering and ...
Chronic Disorders of the Nervous System are Prime Indications for Regenerative Medicine. Neurona is a clinical-stage biotherapeutics company developing regenerative cell therapies that permanently integrate into neural circuits, replace affected ...
Technologybased inLEIDEN, NETHERLANDS
Approximately one-third of the total of 150,000 Dutch epilepsy patients suffer from epileptic seizures for which medication is either ineffective or not entirely effective. Caregivers of epileptic patients want to be able to be on-site quickly in ...
NightWatch warns caregivers remotely in the event of possible epileptic seizures during sleep. Conceived by Dutch neurologists and recommended by patients. NightWatch consists of a comfortable wireless arm module that closely monitors heart rate and ...
Technologybased inRandersacker, GERMANY
Nowadays, medical technology has to try to keep up with medical research and respond to the increased demands of both doctors and patients. The rapidly developing field of sleep medicine in particular requires innovative solutions. Coming from the ...
16 Bit ADC. Adjustable from 4/s to 512/s, IntelligentConect_02, Colour & Mechanical Coded Inputs, small-web, Robust design but still allows bedside bio-calibration, Frequenz_1_web, Shortest EEG Electrode with Continuous Impedance Check, Add ...
Technologybased inBrooklyn, NEW YORK (USA)
Synchron, an endovascular brain interface company, is a leader in implantable neural interface technology. The clinical-stage company is developing a neuroprosthesis for the treatment of paralysis and the first endovascular implantable ...
Technologybased inCambridge, UNITED KINGDOM
GW is the global leader in developing cannabinoid-based medicines. GW has been researching cannabinoids since 1998 and has established a world leading position in the development of plant-derived cannabinoid therapeutics. GW has established a world ...
Many of the childhood-onset intractable epilepsy conditions within the expanded access program share considerable overlap with ASD and these conditions often fall within the orphan disease space. Initial clinical observations from ...